Methamphetamine (MA) use disorder poses a significant public health challenge, particularly given the rise in MA-involved overdoses over the past decade. Despite the severity of this issue, there is ...

Contrave (naltrexone/bupropion) is a prescription drug used for weight loss and long-term weight management in certain adults. The drug is prescribed along with diet ...

A study by Ethan Lazarus, MD, in Obesity Pillars presents a comprehensive review of the appropriate use of the fixed-dose, extended-release combination of naltrexone and bupropion (NB-ER) for the ...

Contrave (naltrexone/bupropion) and Wegovy (semaglutide) are brand-name drugs. They’re both prescribed for weight loss in adults. This article explains the main ...

The mechanisms underlying food cravings and obesity appear to overlap with dopaminergic signaling in the brain and the pathways involved in addiction. As a result, patients who are differentially ...

The European Medicines Agency (EMA) has concluded a review of the weight loss drug naltrexone/bupropion (Mysimba), which was prompted by concerns about potential long-term cardiovascular risks. The ...

Contrave should be avoided in people with certain health conditions, such as unmanaged high blood pressure, seizures, or a history of eating disorders like bulimia or anorexia. Contrave may interact ...